GlassScriptPhysician profile
Philip J Carolin
NPI 1396241733
$6,425.93
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $2,182 · 2021: $2,321 · 2022: $833 · 2023: $16.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,135.98 | 2019-2021 | |
| Stryker Corporation | $2,024.71 | 2021-2022 | |
| Kerecis Limited | $348.64 | 2020-2022 | |
| Medical Device Business Services, INC. | $319.99 | 2020 | |
| Orthofix Medical, INC. | $312.63 | 2020-2021 | |
| Integra Lifesciences Corporation | $199.57 | 2019-2021 | |
| In2bones USA, LLC | $184.05 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $139.27 | 2020-2021 | |
| Organogenesis INC. | $135.18 | 2021-2023 | Puraply |
| Abbott Laboratories | $131.00 | 2020 | |
| Bioventus LLC | $108.82 | 2022 | |
| Acell, INC. | $108.63 | 2019 | |
| Nevro Corp. | $95.58 | 2022 | |
| Paragon 28, INC. | $56.51 | 2021-2022 | |
| Smith+Nephew, INC. | $53.72 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.93 | 2022 | |
| Sebela Pharmaceuticals INC. | $24.10 | 2022 | |
| Paratek Pharmaceuticals, INC. | $22.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Carolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.